philipn / COVID-19 therapeutics ec8d595a82ac00f5ede4f2b6d6ee326798c6b51b

Create Draft
Adding some more antivirals
Review changes View this version of the page
You can also use the and keys
Deletions are marked like this Additions are marked like this

Theraputics are medications/treatments designed to combat an infection. This is in contrast to vaccines, which prevent a disease from occuring. As vaccines may not be widely available for some time, theraputics for COVID-19 could play an important role in the epidemic.

This page details potential COVID-19 theraputics. Substances listed here are not necessarily effective. Potential medications are detailed because they are on trial for use in COVID-19 or have been described as a potential treatment in an academic paper.

Anti-virals

  • Convalescent plasma
  • Remdesivir
  • EIDD-2801
  • Favipiravir
  • Hydroxychloroquine and Chloroquine

Host response

  • Dexamethasone
  • Tocilizumab

See also

Theraputics are medications/treatments designed to combat an infection. This is in contrast to vaccines, which prevent a disease from occuring. As vaccines may not be widely available for some time, theraputics for COVID-19 could play an important role in the epidemic.

This page details potential COVID-19 theraputics. Substances listed here are not necessarily effective. Potential medications are detailed because they are on trial for use in COVID-19 or have been described as a potential treatment in an academic paper.

Anti-virals

  • Convalescent plasma
  • Remdesivir
  • EIDD-2801
  • Favipiravir
  • Hydroxychloroquine and Chloroquine
  • Dipyridamole
  • Niclosamide
  • Nitazoxanide
  • Doxycycyline
  • Ciclesonide
  • Interferons
  • Camostat mesylate
  • Indomethacin
  • Bromhexine
  • Galidesivir

Host response

  • Dexamethasone
  • Tocilizumab

See also
Create Draft
Contributed by
Except where otherwise noted, text content is licensed under a Creative Commons Attribution-ShareAlike License. See copyright information.